Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet. 2021;397(10269):72–4. Article CAS PubMed Google Scholar Walsh EE, Frenck RW, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020;383(25):2439–50. Article CAS PubMed ...
Is there a limit to the number of vaccine doses a person can safely receive? 0:50 min Is it safe to vaccinate older adults who have chronic medical conditions (such as diabetes or hypertension)? 1:15 min Can COVID-19 vaccines cause AIDS?
a vaccine is the single event that will help us turn the page. Vaccines typically take years to develop. Not this time. A month ago, the first American vaccine candidate went into Phase 3 clinical trials, which means we could be very close. And there are a number of other promising...
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants Krishna Mohan Vadrevu Brunda Ganneru Krishna Ella ArticleOpen Access14 Jul 2022 Scientific Reports SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network...
vaccine comments were accompanied by agreement emojis (i.e., “like” and “love”); whereas there was no significant difference between pro-vaccine comments and anti-vaccine comments in reactance when the pro-vaccine comments were accompanied by rejection emojis (i.e., “angry” and “sad”)...
Vaccine literacy of healthcare workers (HCWs) may affect the COVID-19 vaccine uptake of the general population. This study aimed to clarify the vaccine literacy level of HCWs in Japan and its impacts on their concerns about vaccines and intention to recommend that others receive vaccines. This ...
Combo COVID-19 and Flu mRNA Vaccine Falls Short of Total Flu Protection Samantha Anderer September 13, 2024 Expand REVIEW Review Low-Dose Corticosteroids for Adults With Severe Pulmonary Infections Romain Pirracchio, MD, MPH, PhD, Balasubramanian Venkatesh, MD et al. ...
Coronavirus Vaccine The CDC recommends that everyone 6 months and older be vaccinated. There are fourvaccines, which have been granted FDA approval; Pfizer BioNTech, Moderna, Novavax, and Johnson & Johnson. Pfizer and Moderna have developed bivalent boosters, which are so named because they protect...
Metabolic syndrome and the immunogenicity of Pfizer–BioNTech vaccine: a cross-sectional study in Japanese healthcare workers The clustering of metabolic abnormalities may weaken vaccine-induced immunity, but epidemiological data regarding SARS-CoV-2 vaccines are scarce. The present study aimed to examin...
Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403-416. doi:10.1056/NEJMoa2035389PubMedGoogle ScholarCrossref 11. Kildegaard H, Lund LC, Højlund M, Stensballe LG, Pottegård A. Risk of adverse events after covid-19 ...